Bingxiang Zhao

535 total citations
18 papers, 440 citations indexed

About

Bingxiang Zhao is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Bingxiang Zhao has authored 18 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Biomaterials. Recurrent topics in Bingxiang Zhao's work include Nanoparticle-Based Drug Delivery (4 papers), Inflammatory Bowel Disease (3 papers) and Gut microbiota and health (3 papers). Bingxiang Zhao is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Inflammatory Bowel Disease (3 papers) and Gut microbiota and health (3 papers). Bingxiang Zhao collaborates with scholars based in China and New Zealand. Bingxiang Zhao's co-authors include Qiang Zhang, Xuan Zhang, Yue Huang, Kefu Yu, Yang Zhao, Ping Song, Xiyu Ke, Xin Zhao, Yue Huang and Xin Zhao and has published in prestigious journals such as Biomaterials, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Bingxiang Zhao

15 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bingxiang Zhao China	11	223	214	141	82	52	18	440
Navid Goodarzi Iran	12	222 1.0×	171 0.8×	133 0.9×	62 0.8×	65 1.3×	25	456
Wei-Lun Tang Canada	9	219 1.0×	146 0.7×	176 1.2×	69 0.8×	59 1.1×	10	443
Tangna Hao China	10	247 1.1×	151 0.7×	161 1.1×	56 0.7×	62 1.2×	16	405
Guichen Zhou China	8	259 1.2×	214 1.0×	174 1.2×	65 0.8×	109 2.1×	9	505
Linlin Shi China	8	200 0.9×	150 0.7×	162 1.1×	50 0.6×	38 0.7×	9	388
Subhas Bhowmick India	11	201 0.9×	127 0.6×	118 0.8×	63 0.8×	50 1.0×	14	344
Mukesh Ukawala India	7	204 0.9×	119 0.6×	123 0.9×	98 1.2×	66 1.3×	9	379
Noor Alam India	13	298 1.3×	225 1.1×	153 1.1×	140 1.7×	79 1.5×	14	574
Fanglin Yu China	15	261 1.2×	327 1.5×	174 1.2×	62 0.8×	89 1.7×	35	693
Zhongyue Yuan China	10	186 0.8×	171 0.8×	138 1.0×	47 0.6×	53 1.0×	15	430

Countries citing papers authored by Bingxiang Zhao

Since Specialization

Citations

This map shows the geographic impact of Bingxiang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingxiang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingxiang Zhao more than expected).

Fields of papers citing papers by Bingxiang Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingxiang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingxiang Zhao. The network helps show where Bingxiang Zhao may publish in the future.

Co-authorship network of co-authors of Bingxiang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Bingxiang Zhao. A scholar is included among the top collaborators of Bingxiang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingxiang Zhao. Bingxiang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ge, Yuchen, Bingxiang Zhao, Man Li, et al.. (2025). Experimental and network pharmacology certify itraconazole mitigates fluorouracil-induced intestinal damage by inhibiting mTOR-mediated intestinal senescence. Toxicology and Applied Pharmacology. 502. 117404–117404.

Zhao, Bingxiang, Zhenlin Liu, Xiang Li, et al.. (2025). Network pharmacology and experimental validation reveal Thiamphenicol ameliorates dextran sulfate sodium-induced colitis in mice via inhibition of intestinal senescence and modulation of the NF-κB/AMPK signaling pathway. Toxicology and Applied Pharmacology. 503. 117497–117497.

Zhao, Bingxiang, Yingjie Xu, Zhenlin Liu, et al.. (2025). Sparfloxacin ameliorates DSS-induced ulcerative colitis by suppressing cellular senescence, JAK/NF-κB signaling pathway and modulation of the gut microbiota-metabolite axis. Biochemical Pharmacology. 241. 117167–117167. 1 indexed citations

Huang, Mingming, Yingjie Xu, Bingxiang Zhao, et al.. (2025). Miconazole alleviates colitis by suppressing colonic senescence, NF-κB Signaling and gut microbiota modulation. Toxicology and Applied Pharmacology. 503. 117488–117488.

Wang, Zhiwei, Yuchen Ge, Bingxiang Zhao, et al.. (2025). Vorinostat attenuates UVB-induced skin senescence by modulating NF-κB and mTOR signaling pathways. Scientific Reports. 15(1). 10905–10905. 4 indexed citations

Lin, Yuanyuan, et al.. (2025). Droplet Size Reduction of Self-Emulsifying Drug Delivery System (SEDDS) Using the Hybrid of Medium and Long-Chain Triglycerides. Pharmaceutics. 17(7). 822–822. 1 indexed citations

Peng, Chengxin, Bingxiang Zhao, Meng Xie, et al.. (2024). Effect of NiO Addition on the Sintering and Electrochemical Properties of BaCe0.55Zr0.35Y0.1O3-δ Proton-Conducting Ceramic Electrolyte. Membranes. 14(3). 61–61. 11 indexed citations

Zhao, Bingxiang, et al.. (2024). Ultraviolet Light Causes Skin Cell Senescence: From Mechanism to Prevention Principle. Advanced Biology. 9(2). e2400090–e2400090. 10 indexed citations

Dang, Jing, Jian Shu, Ruiying Wang, et al.. (2023). The glycopatterns of Pseudomonas aeruginosa as a potential biomarker for its carbapenem resistance. Microbiology Spectrum. 11(6). e0200123–e0200123. 5 indexed citations

10.

Zhao, Bingxiang, et al.. (2017). Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A. International Journal of Pharmaceutics. 535(1-2). 164–171. 47 indexed citations

11.

Zhou, Xuefei, Xiangrui Liu, Bingxiang Zhao, et al.. (2016). Jumping the nuclear envelope barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306. Journal of Controlled Release. 234. 90–97. 12 indexed citations

12.

Luo, Limin, Yue Huang, Bingxiang Zhao, et al.. (2012). Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel. Biomaterials. 34(4). 1102–1114. 87 indexed citations

13.

Zhao, Bingxiang, Yang Zhao, Yue Huang, et al.. (2011). The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Biomaterials. 33(8). 2508–2520. 89 indexed citations

14.

Wang, Ying, Bingxiang Zhao, Xin Zhao, et al.. (2011). A Novel Paclitaxel Microemulsion Containing a Reduced Amount of Cremophor EL: Pharmacokinetics, Biodistribution, and In Vivo Antitumor Efficacy and Safety. BioMed Research International. 2011(1). 854872–854872. 29 indexed citations

15.

Zhang, Chunhui, Bingxiang Zhao, Yue Huang, et al.. (2011). A Novel Domperidone Hydrogel: Preparation, Characterization, Pharmacokinetic, and Pharmacodynamic Properties. Journal of Drug Delivery. 2011. 1–9. 15 indexed citations

16.

Ke, Xiyu, Xin Zhao, Ying Wang, et al.. (2010). The therapeutic efficacy of conjugated linoleic acid – Paclitaxel on glioma in the rat. Biomaterials. 31(22). 5855–5864. 66 indexed citations

17.

Huang, Yue, Xiaomei Chen, Bingxiang Zhao, et al.. (2010). Antiangiogenic Activity of Sterically Stabilized Liposomes Containing Paclitaxel (SSL-PTX): In Vitro and In Vivo. AAPS PharmSciTech. 11(2). 752–759. 21 indexed citations

18.

Ke, Xiyu, Yue Huang, Xiaomei Chen, et al.. (2010). The antiangiogenic efficacy of NGR-modified PEG–DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats. Journal of drug targeting. 19(5). 382–390. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact